Produktname:(S)-4-(tert-Butoxycarbonyl)-1,4-oxazepane-2-carboxylic acid

IUPAC Name:(2S)-4-[(tert-butoxy)carbonyl]-1,4-oxazepane-2-carboxylic acid

CAS:1273567-44-4
Molekulare Formel:C11H19NO5
Reinheit:95%
Katalognummer:CM284795
Molekulargewicht:245.28

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM284795-1g in stock ƄƄǯ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:1273567-44-4
Molekulare Formel:C11H19NO5
Schmelzpunkt:-
SMILES-Code:O=C([C@H]1OCCCN(C(OC(C)(C)C)=O)C1)O
Dichte:
Katalognummer:CM284795
Molekulargewicht:245.28
Siedepunkt:384.0±42.0°C at 760 mmHg
Mdl-Nr.:MFCD19442252
Lagerung:Store at 2-8°C.

Column Infos

Brensocatib
May 28 2024, Insmed announced positive topline results from landmark ASPEN study of Brensocatib in patients with bronchiectasis.
Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1) being developed for the treatment of patients with bronchiectasis, CRSsNP, and other neutrophil-mediated diseases. DPP1 is an enzyme responsible for activating neutrophil serine proteases (NSPs), such as neutrophil elastase, in neutrophils when they are formed in the bone marrow. Brensocatib is an investigational drug product that has not been approved for any indication in any jurisdiction.

Related Products